New Delhi, (#thestates.news)
Registration for the human clinical trial of
indigenously-developed Covid-19 vaccine Covaxin has started in All India
Institute of Medical Sciences here on
Monday.
AIIMS, Delhi, which is among 12 institutes selected by the Indian Council for
Medical Research for conducting phase I
and II human trials of the vaccine, started registration process of enrolling
healthy individuals as volunteers for the human trials of Covaxin.
As many as 100 volunteers of the about 375 volunteers who will be administered
the drug during phase I will be from AIIMS. (uni) (#mediasaheb.com)
Registration begins for human clinical trial of Covaxin at AIIMS
